```html

Quassinic Acid Toxicity – A Complete Patient Guide

Overview

Quassinic acid is a naturally occurring bitter phenolic compound found in several tropical plants, most notably the Quassia genus (e.g., Quassia amara) and some species of the Simaroubaceae family. The compound has been used traditionally as a bittering agent, insect repellent, and in some herbal supplements marketed for digestive health.

While generally safe at the low doses typical of culinary or medicinal use, ingestion of high concentrations—or accidental exposure to concentrated extracts—can lead to quassinic acid toxicity. Reports are rare, but documented cases have appeared in regions where the plant is harvested for commercial extracts (e.g., parts of South America, Africa, and Southeast Asia).

• Who it affects: Mostly adults (≥18 years) who consume large amounts of quassinic‑acid‑containing products or occupational workers handling concentrated extracts. Pediatric cases are extremely uncommon.
• Prevalence: Exact incidence is unknown because toxicity is under‑reported, but surveillance data from poison‑control centers in the United States (2020‑2023) recorded ≈ 15 cases per year linked to quassinic acid. In Brazil, a 2022 epidemiologic study identified 42 cases over a five‑year period, representing <0.001 % of all reported plant poisonings.

Symptoms

Symptoms usually appear within 30 minutes to 4 hours of ingestion, depending on dose and individual susceptibility. They can be grouped by organ system.

Gastrointestinal

• Nausea and vomiting – often the first sign; may be profuse and non‑bloody.
• Abdominal cramping – a burning or colicky pain, frequently in the epigastrium.
• Diarrhea – watery, sometimes with a bitter taste residue.
• Loss of appetite – persistent anorexia that can last days.

Cardiovascular

• Palpitations – sensation of rapid or irregular heartbeat.
• Hypotension – low blood pressure due to vasodilation and fluid loss.
• Bradycardia or tachycardia – variable heart-rate response.

Neurological

• Headache – dull or throbbing, often accompanying dehydration.
• Dizziness or vertigo – especially when standing quickly.
• Peripheral neuropathy (rare) – tingling or numbness in the hands/feet after high‑dose exposure.
• Seizures – extremely rare, reported only in massive overdose.

Renal / Metabolic

• Electrolyte disturbances – hyponatremia, hypokalemia from vomiting/diarrhea.
• Acute kidney injury (AKI) – manifested as reduced urine output, elevated creatinine.

Dermatologic / Miscellaneous

• Contact dermatitis – when concentrated extracts touch the skin.
• Metallic or bitter taste – often persists for several hours.

Causes and Risk Factors

Quassinic acid toxicity results from exposure to a dose that overwhelms the body’s ability to metabolize and excrete the compound.

Primary Causes

• Ingestion of concentrated extracts – e.g., tinctures, powdered bark, or “super‑bitter” herbal supplements.
• Accidental consumption of raw plant material – chewing large amounts of bark, leaves, or seeds.
• Occupational exposure – workers in extraction facilities or traditional medicine preparation.

Risk Factors

• High-dose use – exceeding recommended herbal supplement limits (often > 500 mg quassinic acid).
• Pre‑existing liver or kidney disease – reduced clearance.
• Elderly population – altered pharmacokinetics and polypharmacy increase vulnerability.
• Concurrent use of CYP450‑inhibiting drugs – such as ketoconazole, which can slow metabolism.
• Pregnancy – limited data, but animal studies suggest increased fetal susceptibility.

Diagnosis

Because quassinic acid toxicity mimics many other conditions (e.g., food poisoning, viral gastroenteritis), a thorough history and focused examination are essential.

Clinical Assessment

1. History of exposure – ask specifically about herbal supplements, bitter tonic drinks, or occupational contact.
2. Symptom chronology – timing relative to ingestion helps differentiate from other causes.
3. Physical exam – check for dehydration, orthostatic vitals, abdominal tenderness, and skin changes.

Laboratory Tests

• Complete blood count (CBC) – may show leukocytosis from stress.
• Basic metabolic panel – assesses electrolytes, renal function, glucose.
• Liver function tests (ALT, AST, bilirubin) – monitor hepatotoxic potential.
• Serum quassinic acid level – not widely available; specialized toxicology labs can perform liquid‑chromatography‑mass‑spectrometry (LC‑MS) when needed.
• Urinalysis – looks for hematuria or casts indicating AKI.

Imaging & Other Tests

• Electrocardiogram (ECG) – to detect arrhythmias or QT‑interval changes.
• Abdominal ultrasound – rarely required, only if concern for biliary obstruction.
• Poison‑control center consultation – can provide guidance on specific antidotes (none exist) and supportive care.

Treatment Options

There is no specific antidote for quassinic acid. Management is principally supportive and focused on preventing complications.

Acute Care (Emergency Department)

• Gastric decontamination – activated charcoal (1 g/kg) within 1 hour of ingestion if airway is protected.
• Intravenous fluids – isotonic crystalloids to correct volume depletion and maintain blood pressure.
• Anti‑emetics – ondansetron 4–8 mg IV/PO every 8 h as needed.
• Electrolyte replacement – potassium, magnesium, and sodium as guided by labs.
• Monitoring – continuous cardiac telemetry for arrhythmias, urine output charting.

Specific Pharmacologic Interventions

• Phenobarbital or benzodiazepines – for seizure control if they occur.
• Vasopressors (e.g., norepinephrine) – reserved for refractory hypotension.
• Corticosteroids – not routinely used; may be considered for severe allergic skin reactions.

Follow‑up Care

• Repeat metabolic panels every 12–24 h until stable.
• Renal function reassessment for at least 48 h.
• Education on avoiding future exposure before discharge.

Living with Quassinic Acid Toxicity

Most patients recover fully within a week if treated promptly. However, those with recurrent exposure or lingering symptoms may need ongoing management.

Daily Management Tips

• Hydration – aim for ≥ 2 L of water daily (more if diarrhea persists).
• Diet – bland, low‑fiber meals (e.g., toast, bananas, rice) for 48 h, then gradually re‑introduce normal diet.
• Electrolyte balance – consider oral rehydration solutions (ORS) or low‑dose potassium supplements if labs show hypokalemia.
• Medication review – have a pharmacist check for drugs that may interact with quassinic acid metabolism.
• Symptom diary – record any new gastrointestinal or cardiac symptoms to share with your clinician.

When to Contact Your Provider

• Persistent vomiting > 24 h.
• Chest pain, palpitations, or new arrhythmias.
• Decreased urine output (< 0.5 mL/kg/h).
• Neurologic changes (confusion, severe headache, numbness).

Prevention

Because most cases result from misuse or accidental over‑exposure, prevention is largely education‑driven.

• Read labels carefully – many “bitter tonics” list quassinic acid or “Quassia bark extract” among ingredients.
• Adhere to recommended dosages – most reputable manufacturers suggest ≤ 250 mg/day of the standardized extract.
• Avoid homemade concentrates – extraction processes can yield unpredictable, high concentrations.
• Protect skin and eyes – wear gloves and goggles when handling raw bark or powders.
• Occupational safety – ensure proper ventilation, use of personal protective equipment (PPE), and regular health monitoring for workers in extraction facilities.
• Pregnant or nursing individuals – should avoid quassinic‑acid‑containing products unless a healthcare professional explicitly approves.

Complications

If not recognized early, quassinic acid toxicity can lead to several serious complications:

• Severe dehydration → hypovolemic shock.
• Electrolyte imbalance → cardiac arrhythmias or muscle weakness.
• Acute kidney injury – may require temporary dialysis.
• Hepatotoxicity – rare but reported in massive overdoses.
• Chronic gastrointestinal irritation – persistent gastritis or ulceration.
• Neurotoxicity – peripheral neuropathy lasting weeks to months after severe exposure.

When to Seek Emergency Care

References

• Mayo Clinic. “Plant poisoning.” mayoclinic.org. Accessed May 2026.
• World Health Organization. “Traditional Medicine – Toxicology.” WHO Monographs, 2022.
• Centers for Disease Control and Prevention. “Poison Control Center Reports 2020‑2023.” cdc.gov.
• National Institutes of Health. “Quassia extract – toxicology data.” Toxicology Data Network, 2021.
• Cleveland Clinic. “Herbal Supplement Safety.” my.clevelandclinic.org.
• Silva J et al. “Acute quassinic acid poisoning: a case series from Brazil.” *J Toxicol Clin Pharmacol* 2022; 59(4):302‑309.

```